270 related articles for article (PubMed ID: 35679071)
1. The interaction between anti-PF4 antibodies and anticoagulants in vaccine-induced thrombotic thrombocytopenia.
Singh A; Toma F; Uzun G; Wagner TR; Pelzl L; Zlamal J; Freytag V; Weich K; Nowak-Harnau S; Rothbauer U; Althaus K; Bakchoul T
Blood; 2022 Jun; 139(23):3430-3438. PubMed ID: 35679071
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic anti-PF4 immune disorders: HIT, VITT, and beyond.
Greinacher A; Warkentin TE
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):1-10. PubMed ID: 38066843
[TBL] [Abstract][Full Text] [Related]
3. Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia.
Huynh A; Kelton JG; Arnold DM; Daka M; Nazy I
Nature; 2021 Aug; 596(7873):565-569. PubMed ID: 34233346
[TBL] [Abstract][Full Text] [Related]
4. Antibodies against platelet factor 4 and the risk of cerebral venous sinus thrombosis in patients with vaccine-induced immune thrombotic thrombocytopenia.
Huynh A; Arnold DM; Ivetic N; Clare R; Hadzi-Tosev M; Liu Y; Smith JW; Bissola AL; Daka M; Kelton JG; Nazy I
J Thromb Haemost; 2023 Oct; 21(10):2833-2843. PubMed ID: 37394121
[TBL] [Abstract][Full Text] [Related]
5. Heparin-induced thrombocytopenia--therapeutic concentrations of danaparoid, unlike fondaparinux and direct thrombin inhibitors, inhibit formation of platelet factor 4-heparin complexes.
Krauel K; Fürll B; Warkentin TE; Weitschies W; Kohlmann T; Sheppard JI; Greinacher A
J Thromb Haemost; 2008 Dec; 6(12):2160-7. PubMed ID: 18983520
[TBL] [Abstract][Full Text] [Related]
6. Investigation of anti-PF4 versus anti-PF4/heparin reactivity using fluid-phase enzyme immunoassay for 4 anti-PF4 disorders: classic heparin-induced thrombocytopenia (HIT), autoimmune HIT, vaccine-induced immune thrombotic thrombocytopenia, and spontaneous HIT.
Warkentin TE; Arnold DM; Sheppard JI; Moore JC; Kelton JG; Nazy I
J Thromb Haemost; 2023 Aug; 21(8):2268-2276. PubMed ID: 37182698
[TBL] [Abstract][Full Text] [Related]
7. Laboratory Testing for Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia Antibodies: A Narrative Review.
Warkentin TE; Greinacher A
Semin Thromb Hemost; 2023 Sep; 49(6):621-633. PubMed ID: 36455619
[TBL] [Abstract][Full Text] [Related]
8. A novel flow cytometry procoagulant assay for diagnosis of vaccine-induced immune thrombotic thrombocytopenia.
Lee CSM; Liang HPH; Connor DE; Dey A; Tohidi-Esfahani I; Campbell H; Whittaker S; Capraro D; Favaloro EJ; Donikian D; Kondo M; Hicks SM; Choi PY; Gardiner EE; Clarke LJ; Tran H; Passam FH; Brighton TA; Chen VM
Blood Adv; 2022 Jun; 6(11):3494-3506. PubMed ID: 35359002
[TBL] [Abstract][Full Text] [Related]
9. Platelet-activating anti-PF4 disorders: An overview.
Warkentin TE
Semin Hematol; 2022 Apr; 59(2):59-71. PubMed ID: 35512902
[TBL] [Abstract][Full Text] [Related]
10. Quantitative interpretation of PF4/heparin-EIA optical densities in predicting platelet-activating VITT antibodies.
Schönborn L; Thiele T; Esefeld M; El Debuch K; Wesche J; Seck SE; Kaderali L; Wolff M; Warkentin TE; Greinacher A
J Thromb Haemost; 2022 Nov; 20(11):2579-2586. PubMed ID: 36006172
[TBL] [Abstract][Full Text] [Related]
11. Vaccine-induced immune thrombotic thrombocytopenia.
Kanack AJ; Padmanabhan A
Best Pract Res Clin Haematol; 2022 Sep; 35(3):101381. PubMed ID: 36494147
[TBL] [Abstract][Full Text] [Related]
12. Serotonin Release Assay: Functional Assay for Heparin- and Vaccine-Induced (Immune) Thrombotic Thrombocytopenia.
Kondo M; Donikian D; Brighton TA
Methods Mol Biol; 2023; 2663():463-477. PubMed ID: 37204730
[TBL] [Abstract][Full Text] [Related]
13. Unique features of vaccine-induced immune thrombotic thrombocytopenia; a new anti-platelet factor 4 antibody-mediated disorder.
Venier LM; Clerici B; Bissola AL; Modi D; Jevtic SD; Radford M; Mahamad S; Nazy I; Arnold DM
Int J Hematol; 2023 Mar; 117(3):341-348. PubMed ID: 36574172
[TBL] [Abstract][Full Text] [Related]
14. Heparin-Induced Thrombotic Thrombocytopenia (HITT) and Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT): Similar but Different.
Favaloro EJ; Pasalic L
Methods Mol Biol; 2023; 2663():405-415. PubMed ID: 37204726
[TBL] [Abstract][Full Text] [Related]
15. Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein.
Greinacher A; Selleng K; Mayerle J; Palankar R; Wesche J; Reiche S; Aebischer A; Warkentin TE; Muenchhoff M; Hellmuth JC; Keppler OT; Duerschmied D; Lother A; Rieg S; Gawaz MP; Mueller KAL; Scheer CS; Napp M; Hahnenkamp K; Lucchese G; Vogelgesang A; Flöel A; Lovreglio P; Stufano A; Marschalek R; Thiele T;
Blood; 2021 Oct; 138(14):1269-1277. PubMed ID: 34280256
[TBL] [Abstract][Full Text] [Related]
16. Whole Blood Procoagulant Platelet Flow Cytometry Protocol for Heparin-Induced Thrombocytopenia (HIT) and Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Testing.
Lee CSM; Powell MC; Chen VM
Methods Mol Biol; 2023; 2663():441-461. PubMed ID: 37204729
[TBL] [Abstract][Full Text] [Related]
17. [Heparin-induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia: novel insights on anti-platelet factor 4 antibodies].
Atsushi Y
Rinsho Ketsueki; 2022; 63(9):1233-1241. PubMed ID: 36198549
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous HIT syndrome: Knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia.
Warkentin TE; Greinacher A
Thromb Res; 2021 Aug; 204():40-51. PubMed ID: 34144250
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review.
Rizk JG; Gupta A; Sardar P; Henry BM; Lewin JC; Lippi G; Lavie CJ
JAMA Cardiol; 2021 Dec; 6(12):1451-1460. PubMed ID: 34374713
[TBL] [Abstract][Full Text] [Related]
20. Potential mechanisms of vaccine-induced thrombosis.
Marietta M; Coluccio V; Luppi M
Eur J Intern Med; 2022 Nov; 105():1-7. PubMed ID: 35953336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
